S
Stuart M. Greenstein
Researcher at Albert Einstein College of Medicine
Publications - 85
Citations - 1987
Stuart M. Greenstein is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 24, co-authored 85 publications receiving 1820 citations. Previous affiliations of Stuart M. Greenstein include University of Pennsylvania & Montefiore Medical Center.
Papers
More filters
Journal ArticleDOI
Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate
Maria Coco,Daniel Glicklich,Marie Claude Faugere,Larry Burris,Istvan Bognar,Peter Durkin,Vivian A. Tellis,Stuart M. Greenstein,R. S. Schechner,Katherine Figueroa,Patricia McDonough,Guodong Wang,Hartmut H. Malluche +12 more
TL;DR: Pamidronate treatment was associated with development of adynamic bone histology and whether an improved BMD with adynamicBone histology is useful in maintaining long-term bone health in renal transplant recipients requires further study.
Journal ArticleDOI
Compliance and noncompliance in patients with a functioning renal transplant: A multicenter study
TL;DR: Results of this large, multicenter survey designed to identify variables that affect the likelihood of compliance with immunosuppressive medication regimens and distinguish among noncompliant patients can be used by clinicians to identify patients likely to becomeNoncompliant, by researchers to develop randomized, prospective clinical trials of interventions designed to increase compliance, and by educators to tailor patient education programs.
Journal ArticleDOI
COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.
Yorg Azzi,Michael K. Parides,Omar Alani,Pablo Loarte-Campos,Rachel Bartash,Stefanie K. Forest,Adriana I. Colovai,Maria Ajaimy,Luz Liriano-Ward,Cindy Pynadath,Jay A. Graham,Marie Le,Stuart M. Greenstein,Juan P. Rocca,Milan Kinkhabwala,Enver Akalin +15 more
TL;DR: In multivariable analysis, older age, receipt of deceased-donor transplantation, lack of influenza vaccination in the previous year and higher serum interleukine-6 levels were associated with mortality.
Journal ArticleDOI
Percutaneous transluminal angioplasty. The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis.
Stuart M. Greenstein,Anthony Verstandig,Gordon K. McLean,Donald C. Dafoe,Dana R. Burke,S G Meranze,Ali Naji,Robert A. Grossman,Perloff Lj,Clyde F. Barker +9 more
TL;DR: Compared with operation, PTA is a safer and more effective procedure for the initial treatment of RTAS and in patients with functioning kidneys at a mean follow-up period of 30 months.
Journal ArticleDOI
Postrenal Transplant Compliance From the Perspective of African-Americans, Hispanic-Americans, and Anglo-Americans
TL;DR: Findings revealed that 96 (18%) of the transplant recipients had been noncompliant with immunosuppressive medications, including African-American patients, which challenge conventional thinking.